Crystal structure of the major quadruplex formed in the promoter region of the human c-MYC oncogene
- Univ. of Montana, Missoula, MT (United States); DOE/OSTI
- Univ. of Montana, Missoula, MT (United States)
The c-MYC oncogene mediates multiple tumor cell survival pathways and is dysregulated or overexpressed in the majority of human cancers. The NHE III1 region of the c-MYC promoter forms a DNA quadruplex. Stabilization of this structure with small molecules has been shown to reduce expression of c-MYC, and targeting the c-MYC quadruplex has become an emerging strategy for development of antitumor compounds. Previous solution NMR studies of the c-MYC quadruplex have assigned the major conformer and topology of this important target, however, regions outside the G-quartet core were not as well-defined. Here, we report a high-resolution crystal structure (2.35 Å) of the major quadruplex formed in the NHE III1 region of the c-MYC promoter. The crystal structure is in general agreement with the solution NMR structure, however, key differences are observed in the position of nucleotides outside the G-quartet core. The crystal structure provides an alternative model that, along with comparisons to other reported quadruplex crystal structures, will be important to the rational design of selective compounds. This work will aid in development of ligands to target the c-MYC promoter quadruplex with the goal of creating novel anticancer therapies.
- Research Organization:
- SLAC National Accelerator Lab., Menlo Park, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES)
- Grant/Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1627869
- Journal Information:
- PLoS ONE, Journal Name: PLoS ONE Journal Issue: 10 Vol. 13; ISSN 1932-6203
- Publisher:
- Public Library of ScienceCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Solution Structure of a MYC Promoter G-Quadruplex with 1:6:1 Loop Length
|
journal | February 2019 |
Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches
|
text | January 2019 |
Evaluation of an Analogue of the Marine ε-PLL Peptide as a Ligand of G-quadruplex DNA Structures
|
journal | January 2020 |
Developing Novel G-Quadruplex Ligands: from Interaction with Nucleic Acids to Interfering with Nucleic Acid–Protein Interaction
|
journal | January 2019 |
Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches
|
journal | December 2018 |
Similar Records
NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III[subscript 1]
Posttranscriptional regulation of cellular gene expression by the c-myc oncogene
Crystallization and Characterization of the Thallium Form of the Oxytricha Nova G-Quadruplex
Journal Article
·
Wed May 13 00:00:00 EDT 2009
· Mol. Cancer Ther.
·
OSTI ID:1018555
Posttranscriptional regulation of cellular gene expression by the c-myc oncogene
Journal Article
·
Sat Dec 31 23:00:00 EST 1988
· Molecular and Cellular Biology; (USA)
·
OSTI ID:5407181
Crystallization and Characterization of the Thallium Form of the Oxytricha Nova G-Quadruplex
Journal Article
·
Sat Dec 31 23:00:00 EST 2005
· Nucleic Acids Research
·
OSTI ID:930204